EXELIXIS, INC.

EXELNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$2.3B

▲ 7.0% YoY

Net Income

$782.6M

▲ 50.1% YoY

EPS

$2.78

▲ 58.0% YoY

Cash

$482.5M

▲ 122.0% YoY

FY 2026 · As of 2026-01-02

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.